Zobrazeno 1 - 10 of 176 pro vyhledávání: '"F M, Lu"'
1
[Some HBeAg-negative chronic hepatitis B patients treated with nucleos(t)ide analogue can achieve HBsAg loss after drug withdrawal: stop-to-cure may be coming]
Autor: F M, Lu, Y C, Yu, L, Gao, Q Q, Jiang, X M, Chen, Hui, Zhuang
Publikováno v: Zhonghua yi xue za zhi. 102(40)
Nucleoside/Nucleotide analogues (NAs) are widely used for the antiviral treatment of chronic hepatitis B (CHB), however, it is difficult to achieve serum hepatitis B surface antigen (HBsAg) loss with NAs therapy. In recent years, several prospective
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e9bae231870783070b674bf8cd702662
https://pubmed.ncbi.nlm.nih.gov/36319170
Zobrazit plný text záznamu
2
[Mechanism and clinical significance of HBV reactivation after anti-HCV therapy]
Autor: W J, Zeng, L, Gao, Y W, Xu, X M, Chen, F S, Wang, F M, Lu
Publikováno v: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology. 30(9)
Direct-acting antivirals (DAAs) can strongly inhibit the replication of hepatitis C virus (HCV) and effectively clear the infection, but it may cause hepatitis B virus (HBV) reactivation, leading to severe liver damage and fulminate hepatitis in pati
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::36b3600a9fd1779b473728b2ff1f4a67
https://pubmed.ncbi.nlm.nih.gov/36299197
Zobrazit plný text záznamu
3
[Consideration on the possible etiological mechanisms and countermeasures about severe acute hepatitis of unknown origin in children]
Autor: L J, Wang, G X, Yu, Y, Wu, X Y, Yang, Y, Gao, L, Wang, X M, Chen, F M, Lu
Publikováno v: Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]. 56(10)
Since April 2022, severe acute hepatitis of unknown origin in children has spread to 35 countries and regions around the world, and more than 1 010 cases have been reported. Since the severe acute hepatitis of unknown origin involves a wide range of
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::0e2208a835002ad55c94679daa914e06
https://pubmed.ncbi.nlm.nih.gov/36274621
Zobrazit plný text záznamu
4
[A short half-life of cccDNA offer or ignite hope for hepatitis B cure under nucleos(t)ide analogues treatment]
Autor: L, Gao, T H, Mao, S W, Peng, J, Wang, X M, Chen, F M, Lu
Publikováno v: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology. 30(1)
Covalently closed circular DNA (cccDNA) of hepatitis B virus (HBV) is the template for HBV replication. Currently, there is a lack of therapeutic drugs that directly target cccDNA. Therefore, blocking cccDNA supplements as fast as possible and reduci
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::1491d319470afdfbf4182e0b918c7e5e
https://pubmed.ncbi.nlm.nih.gov/35152678
Zobrazit plný text záznamu
5
[Clinical application of serum Golgi protein 73 in patients with chronic liver diseases]
Autor: Y N, Liu, M J, Yao, S J, Zheng, X M, Chen, X Y, Liu, P, Hu, Q S, Ou, X G, Dou, H S, Chen, Z P, Duan, J L, Hou, Y M, Nan, Z L, Gao, X Y, Xu, H, Zhuang, F M, Lu
Publikováno v: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology. 30(1)
Golgi protein 73 (GP73) is a transmembrane protein on the Golgi apparatus and can be cut and released into the blood. In recent years, an increasing number of clinical studies have shown that the elevated serum GP73 level is closely related to liver
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b375798ffa12bf5a8871b5eac1688c97
https://pubmed.ncbi.nlm.nih.gov/35152664
Zobrazit plný text záznamu
6
[A possible mechanism for low-level viremia occurrence in nucleos(t)ide analog-treated chronic hepatitis B patients]
Autor: L J, Wang, Z Q, Gu, Z M, Xu, X M, Chen, F M, Lu
Publikováno v: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology. 29(12)
The first-line nucleos(t)ide analogs (NAs) based antiviral drugs can effectively inhibit HBV replication and slow down the progression of chronic hepatitis B. However, about 20% of patients receiving standard NAs antiviral therapy will still develop
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::3bd7e982908120105290c07b8e0a1c64
https://pubmed.ncbi.nlm.nih.gov/35045629
Zobrazit plný text záznamu
7
[The mechanisms of the translation of polymerase from HBV pregenomic RNA]
Autor: D J, Lu, H L, Zheng, J Y, Xi, T, Zhang, X M, Chen, F M, Lu
Publikováno v: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology. 29(10)
Hepatitis B virus (HBV) is an important pathogen that causes different liver diseases such as viral hepatitis and liver cirrhosis. HBV pregenomic RNA (pgRNA) plays a crucial role in HBV life cycle, which is not only the translation template of core (
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d6053bbbf515841569631ea243f8e79e
https://pubmed.ncbi.nlm.nih.gov/34814405
Zobrazit plný text záznamu
8
[The Clinical Significance and Mechanism of the Effect for Hepatitis B Virus Protein on Host Immune]
Autor: L J, Wang, W J, Zeng, D Y, Li, X M, Chen, F M, Lu
Publikováno v: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology. 29(7)
The cytotoxic effect targeting hepatitis B virus (HBV) infected hepatocytes from virus-specific cytotoxic T cells and the neutralizing antibodies secreted by virus-specific B cells play an important role in the immune control and elimination of HBV.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::c65194c78eb75693099817d5aed8b4db
https://pubmed.ncbi.nlm.nih.gov/34371532
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje